Printer Friendly

CELLEGY NAMES NEW BOARD MEMBER

 CELLEGY NAMES NEW BOARD MEMBER
 NOVATO, Calif., July 29 /PRNewswire/ -- Cellegy Pharmaceuticals


Inc. announced the appointment of Robert A. McCabe, 58, to the company's board of directors. This brings the total number of directors to four.
 McCabe is the president of Pilot Capital Corp., a New York investment firm. He was previously a managing director of Lehman Brothers.
 McCabe serves on several boards of directors, including Morrison- Knudsen, Neutrogena Corp., Thermo Electron Corp., Thermo Instruments Systems and Church & Dwight Co. Inc.
 Cellegy Pharmaceutical Inc. is a privately held biopharmaceutical company focusing on the development of novel dermatological therapeutic products to prevent skin disorders, minimize the effects of aging and treat chronic skin diseases.
 -0- 7/29/92
 /CONTACT: Mark Brand of Pondel Parsons & Wilkinson, 310-207-9300, for Cellegy Pharmaceuticals/ CO: Cellegy Pharmaceuticals Inc. ST: California IN: MTC SU: PER


LS-JL -- LA024 -- 4712 07/29/92 15:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 29, 1992
Words:147
Previous Article:CASTING PLANT MANAGER BIDS FAREWELL TO FORD AFTER 35 YEARS
Next Article:HALIFAX DECLARES SEMIANNUAL DIVIDEND
Topics:


Related Articles
CELLEGY EXPANDS MANAGEMENT STAFF
CELLEGY BOLSTERS PRODUCT DEVELOPMENT CAPABILITIES: APPOINTS VICE PRESIDENT, RESEARCH AND DEVELOPMENT, AND DIRECTOR OF CLINICAL TRIALS
DR. DENIS BURGER TO JOIN CELLEGY BOARD
CELLEGY PHARMACEUTICALS, INC.: WILLIAM E. BLISS APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER
CELLEGY APPOINTS V.P. CORPORATE DEVELOPMENT
Ronald J. Saldarini Joins Cellegy's Board of Directors.
Cellegy Responds to FDA Inquiries Concerning Cellegesic(TM).
Cellegy Announces Resignations of Two Board Members.
FDA Issues Approvable Letter to Cellegy Pharmaceuticals for Cellegesic(R).
Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters